XENE
Xenon Pharmaceuticals Inc. · Healthcare
Director Simon N. Pimstone sold $1.6M of Xenon Pharmaceuticals Inc.
Sold$1,609,321
$29.28Price
54,962Shares
−23%Stake
What XENE did after the filing
- The stock from Wed, Mar 9 open, $30.74
- +6.4%
- S&P 500, same days
- +3.4%
Measured over 30 trading days, to the Apr 21 close.
Traded Fri, Mar 4. Filed Tue, Mar 8. Returns use the Mar 9 open and the Apr 21 close. Not investment advice.